Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission Results of a multivariate analysis

Strahlentherapie und Onkologie

Volumn 188, Issue 9, 2012, Pages 777-781

  Matuschek, C ^a   Bolke E ^a   Roth, S L ^a   Orth, K ^a   Lang, I ^a   Bojar, H ^a   Janni, J W ^a   Audretsch, W ^b   Nestle Kraemling, C ^c   Lammering, G ^a,e   Speer, V ^a   Gripp, S ^a   Gerber, P A ^a   Buhren, B A ^a   Sauer, R ^d   Peiper, M ^a   Schauer, M ^a   Dommach, M ^f   Struse Soll, K ^f   Budach, W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MARIEN HOSPITAL DÜSSELDORF   (Germany)

^c Krankenhaus Gerresheim   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e MAASTRO CLINIC   (Netherlands)

^f SANA KLINIKUM OFFENBACH   (Germany)

Author keywords

Brustkrebs; Langzeitverlauf; Neoadjuvante Radiochemotherapie; Pathologisch komplette Remission; Prognostische Marker

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GONADORELIN AGONIST; METHOTREXATE; MITOXANTRONE; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CHEMORADIOTHERAPY; COHORT ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LOCALLY ADVANCED NONINFLAMMATORY BREAST CANCER; LONG TERM CARE; MAJOR CLINICAL STUDY; MASTECTOMY; PATHOLOGIC COMPLETE REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; CHEMORADIOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; GERMANY; HUMANS; MASTITIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PREVALENCE; REMISSION INDUCTION; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866657736     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0162-8     Document Type: Article

References (24)

1. Roth SL, Audretsch W, Bojar H et al (2010) Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer: survival advantage in cT2 category by neoadjuvant radiochemotherapy. Strahlenther Onkol 186:299-306
2. Hung WK, Lau Y, Chan CM, Yip AW (2000) Experience of neoadjuvant chemotherapy for breast cancer at a public hospital: retrospective study. Hong Kong Med J 6:265-268
3. Jiralerspong S, Palla SL, Giordano SH et al (2009) Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27:3297-3302
4. Fangberget A, Nilsen LB, Hole KH et al (2011) Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 21:1188-1199
5. Wildiers H, Neven P, Christiaens MR et al (2011) Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer. Ann Oncol 22:588-594
6. Audretsch W, Andree C (2012) Advancements in oncoplastic surgery of the breast. In: Babiera GV et al (eds) Advanced Therapy of Breast Disease, 3rd edn. PMPH, pp 613-642
7. Sataloff DM, Mason BA, Prestipino AJ et al (1995) Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg 180:297-306
8. Cox DR, McCullagh P (1982) Some aspects of analysis of covariance. Biometrics 38:541-561
9. Minckwitz G von, Untch M, Nuesch E et al (2011) Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials. Breast Cancer Res Treat 125:145-156
10. Mauriac L, Durand M, Avril A, Dilhuydy JM (1991) Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. Ann Oncol 2:347-354
11. Fisher B, Bryant J, Wolmark N et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685
12. Scholl SM, Pierga JY, Asselain B et al (1995) Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. Eur J Cancer 31A:1969-1975
13. Shanta V, Swaminathan R, Rama R, Radhika R (2008) Retrospective analysis of locally advanced noninflammatory breast cancer from Chennai, South India, 1990-1999. Int J Radiat Oncol Biol Phys 70:51-58
14. Lerouge D, Touboul E, Lefranc JP et al (2004) Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. Int J Radiat Oncol Biol Phys 59:1062-1073
15. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181-187
16. Koscielny S, Tubiana M, Le MG et al (1984) Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49:709-715
17. Withers HR, Thames HD (1988) Dose fractionation and volume effects in normal tissues and tumors. Am J Clin Oncol 11:313-329
18. Bear HD, Anderson S, Smith RE et al (2006) Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 24:2019-2027
19. Rastogi P, Anderson SJ, Bear HD et al (2008) Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 26:778-785
20. Fisher B, Dignam J, Wolmark N et al (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441-452
21. Dontu G, Liu S, Wicha MS (2005) Stem cells in mammary development and carcinogenesis: implications for prevention and treatment. Stem Cell Rev 1:207-213
22. Hortobagyi GN, Ames FC, Buzdar AU et al (1988) Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 62:2507-2516
23. Audretsch W, Rezai M, Kolotas C et al (1994) Oncoplastic surgery: "Target" volume reduction, lumpectomy reconstruction and flap-supported operability in breast cancer. Proceedings 2nd European Congress on Senology, Vienna, Austria, October 2-6. Mendoza Bologna, Italy, pp 139-157
24. Audretsch W, Rezai M, Kolotas C et al (1989) Tumor-specific immediate reconstruction (TSIR) in breast cancer patients. Perspect Plast Surg 11:71-106